Skip to main content
SpringerLink
Log in

Lethal Hereditary Vascular Disorders: Osler-Weber-Rendu Syndrome, Ataxia-Telangiectasia, and Fabry’s Disease

  • Chapter
  • First Online:
Deadly Dermatologic Diseases

  • 886 Accesses

Abstract

Mucocutaneous vascular ectasia, otherwise referred to as telangiectasia, can be an important harbinger of serious systemic disease. Among a variety of acquired conditions, including hepatic cirrhosis, that are responsible for their development, are a heterogeneous group of inherited conditions that entail the development of multiple cutaneous and mucous membrane vascular lesions associated with other life-threatening complications. This chapter deals with the clinical and pathologic features of three such conditions, namely, Osler-Weber-Rendu (OWR) syndrome, ataxia-telangiectasia (AT), and Fabry’s disease (FD).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

OWR

  1. Osler W. On multiple hereditary telangiectasis with recurrent ring hemorrhages. Q J Med. 1907;1:53.

    Google Scholar 

  2. Perry W. The clinical spectrum of hereditary hemorrhagic telangiectasias (Osler-Weber-Rendu disease). Am J Med. 1987;5:989.

    Article  Google Scholar 

  3. Garg N, Khunger M, Gupta A, Kumar N. Optimal management of hereditary hemorrhagic telangiectasia. J Blood Med. 2014;5:191.

    PubMed  PubMed Central  Google Scholar 

  4. Chandler D. Pulmonary and cerebral arteriovenous fistula with Osler’s disease. Arch Intern Med. 1965;116:277.

    Article  CAS  PubMed  Google Scholar 

  5. Swanson D, Dahl M. Embolic abscesses in hereditary hemorrhagic telangiectasia. J Am Acad Dermatol. 1991;24:580.

    Article  CAS  PubMed  Google Scholar 

  6. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: a double blind controlled clinical trial. Acta Med Scand. 1981;209:393.

    Article  CAS  PubMed  Google Scholar 

  7. Dupuis-Girod S, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA. 2012;307:948.

    Article  CAS  PubMed  Google Scholar 

AT

  1. Smith L, Conerly S. Ataxia-telangiectasia or Louis-Bar syndrome. J Am Acad Dermatol. 1985;12:686.

    Article  Google Scholar 

  2. Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet. 2000;92:170.

    Article  CAS  PubMed  Google Scholar 

  3. Khanna K. Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst. 2000;92:795.

    Article  CAS  PubMed  Google Scholar 

  4. Swift M, Morrell D, Massey R, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991;325:1831.

    Article  CAS  PubMed  Google Scholar 

  5. Peterson R, Funkhouser J. Speculations on ataxia-telangiectasia: defective regulation of the immunoglobulin gene superfamily. Immunol Today. 1989;10:313.

    Article  CAS  PubMed  Google Scholar 

  6. Drolet B, Drolet B, Zvulunov A, et al. Cutaneous granulomas as a presenting sign in ataxia-telangiectasia. Dermatology. 1997;194:273.

    Article  CAS  PubMed  Google Scholar 

FD

  1. Anderson W. A case of angiokeratoma. Br J Dermatol. 1898;10:113.

    Article  Google Scholar 

  2. Fabry J. Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nodularis. Arch Dermatol Syphilis. 1898;43:187.

    Article  Google Scholar 

  3. Eng C, Guffon N, Wilcox W, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease. N Engl J Med. 2001;345:9.

    Article  CAS  PubMed  Google Scholar 

  4. Wallace H. Anderson-Fabry disease. Br J Dermatol. 1973;88:1.

    Article  CAS  PubMed  Google Scholar 

  5. Holmes R, Fenson A, McKee P, et al. Angiokeratoma corporis diffusum in a patient with normal enzyme activities. J Am Acad Dermatol. 1984;10:384.

    Article  CAS  PubMed  Google Scholar 

  6. Epinette W, Norins A, Drew A, et al. Angiokeratoma corporis diffusum with a L-fucosidase deficiency. Arch Dermatol. 1973;107:754.

    Article  CAS  PubMed  Google Scholar 

  7. Thomas AS, Hughes DA. Fabry disease. Pediatr Endocronil Rev. 2014;1:88–101.

    Google Scholar 

  8. Fellgiebel A, et al. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease. Cerebrovasc Dis. 2014;38:448–56.

    Article  CAS  PubMed  Google Scholar 

  9. Kizhner T, et al. Characterization of a chemically modified plant cell culture expressed human alpha-galactosidase-A enzyme for treatment of Fabry disease. Mol Genet Metab. 2015;114:259–67.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Director of Dermatopathology, Dermatology Specialists of Florida, Panama City, FL, USA

    Michael B. Morgan

  2. Staff Dermatopathologist, Advanced Dermatology and Cosmetic Surgery, Clermont, FL, USA

    Michael B. Morgan

  3. Professor of Dermatology, Michigan State College of Medicine, East Lancing, USA

    Michael B. Morgan

Authors
  1. Garone Michael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael B. Morgan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael B. Morgan .

Editor information

Editors and Affiliations

  1. Assistant Professor Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

    David R. Crowe

  2. Dermpath Diagnostics, Tampa, Florida, USA

    Michael Morgan

  3. MetroHealth Medical Center, Cleveland, Ohio, USA

    Stephen Somach

  4. Washington, District of Columbia, USA

    Kara Trapp

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Michael, G., Morgan, M.B. (2016). Lethal Hereditary Vascular Disorders: Osler-Weber-Rendu Syndrome, Ataxia-Telangiectasia, and Fabry’s Disease. In: Crowe, D., Morgan, M., Somach, S., Trapp, K. (eds) Deadly Dermatologic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-31566-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31566-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31564-5

  • Online ISBN: 978-3-319-31566-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation